(b) If The chief commissioner establishes a program less than this subchapter, the commissioner shall publish a report not later than January 1 of every odd-numbered 12 months to the clinical performance of the usage of tetrahydrocannabinols as well as their derivatives and another medical results in the exploration system.(d) In analyzing no matte